Stock Track | Burning Rock Biotech Surges 5.9% as CFO Resigns, Replacement Named

Stock Track
2024/09/27

Shares of Burning Rock Biotech Limited (NASDAQ: BNR), a company focused on applying next-generation sequencing (NGS) technology in precision oncology, surged 5.9% on Friday after the company announced changes to its management and board of directors.

The company disclosed that its Chief Financial Officer, Leo Li, has resigned from his position and as a member of the board of directors, effective September 27, 2024. Burning Rock stated that Li's resignation was for personal reasons and not due to any disagreement with the board or issues with the company's operations or practices.

To ensure a smooth transition, Burning Rock has appointed Xiaozhi Hu, the current senior director in finance, to oversee the company's financial operations, financial reporting, and related matters. Hu will report directly to Yusheng Han, the chairman of the board and chief executive officer. The company praised Hu's extensive experience in financial management, having joined Burning Rock in May 2014.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10